## Abstract Antibodies against envelope glycoprotein 1 and 2 (antiβE1/E2) have been suggested to influence HCV replication levels. Hepatitis B virus (HBV) may interfere with hepatitis C virus (HCV) replication. At present there are no data on antiβE1/E2 antibody responses or on the effect of interf
Serological and molecular analysis of hepatitis C virus envelope regions 1 and 2 during acute and chronic infections in chimpanzees
β Scribed by van Doorn, Leen-Jan; van Hoek, Kitty; de Martinoff, Guy; Bosman, Fons; Stuyver, Lieven; Kos, Ton; Frantzen, Inge; Sillekens, Peter; Maertens, Geert; Quint, Wim
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 150 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
β¦ Synopsis
Acute and chronic Hepatitis C virus infections were investigated retrospectively in chimpanzees that had been infected from a single source. Anti-E1 and anti-E2 were detected in two of three chimpanzees with a chronic infection, but were first detected 1 to 2 years after inoculation. Sequence evolution of the E1 region in three animals over a period of 9 to 11 years revealed a mutation rate of 1.02 to 2.23 x 10(-3) base substitutions per site per year. The acute phase viremia levels in acute infections which resolved appeared to be at least 10-fold higher than during the acute phase of chronic infections. During chronic infections, the viral load fell rapidly after the acute phase and remained at very low levels for several years. After 4 to 6 years, the viral load and liver enzymes increased again, suggesting reactivation of the infection. There was no clear temporal relationship between sequence evolution of the E1 region, changes in viral load, and the production of antibodies to the envelope proteins.
π SIMILAR VOLUMES
## Abstract Hepatitis C virus (HCV), exhibits considerable genetic diversity, but presents a relatively well conserved 5β² noncoding region (5β² NCR) among all genotypes. In this study, the structural features and translational efficiency of the HCV 5β² NCR sequences were analyzed using the programs R
The significance of circulating antibody to hepatitis C HCV E1 corresponds to the pestiviral gp33/gp25 envevirus (HCV) envelope glycoprotein 2 (E2)/nonstructural lope glycoprotein and the flaviviral envelope protein protein 1 (NS1) glycoprotein was studied in 83 patients (M/E), whereas E2/NS1 corres
## Abstract The Nβterminal end of the hepatitis C virus (HCV) envelope glycoprotein E2 contains a stretch of 27 amino acids that exhibit increased variability. This hypervariable region 1 (HVRβ1), as it is normally referred to, is thought to contain epitopes that come under humoral immune attack. I
biochemical and histological improvement. 3,4 Several factors Hepatitis C virus (HCV) genotype 1b and high precan predict a poor response to interferon therapy, e.g., high treatment virus load are predictive factors of poor repretreatment virus load, genotype 1b, advanced histological sponse to inte